Duke Eye Center

Summary

Duke Eye Center is a medical facility located in Durham, North Carolina. This center is recognized for care of Macular Degeneration, Glaucoma, Age-Related Macular Degeneration, Retinal Disease, Ocular Hypertension and other specialties. Duke Eye Center is involved with conducting 108 clinical trials across 123 conditions. There are 15 research doctors associated with this hospital, such as Lejla Vajzovic, MD, Cynthia A Toth, MD, Sharon F Freedman, MD, and Ramiro Maldonado, MD.

Top PIs

Clinical Trials running at Duke Eye Center

Age-Related Macular Degeneration

Macular Degeneration

Retinal Disease

Lazy Eye

Glaucoma

Stargardt Disease

Choroidal Neovascularization

Retinal Degeneration

None

Macular Pucker

4D-150 + EYLEA

for Age-Related Macular Degeneration

A Phase 3, Randomized, Double-Masked, Active-Controlled Trial in Adults with Macular Neovascularization Secondary to Age-Related Macular Degeneration

Recruiting

2 awards

Phase 3

4 criteria

RGX-314 Gene Therapy

for Age-Related Macular Degeneration

This trial is testing a new one-time gene therapy called RGX-314 for patients with wet AMD. The goal is to reduce the need for regular treatments by helping the eye produce its own protective proteins. This could make treatment easier and more effective for patients.

Recruiting

2 awards

Phase 3

2 criteria

RGX-314 Gene Therapy

for Wet Age-Related Macular Degeneration

This trial is testing a new one-time gene therapy called RGX-314 for patients with wet AMD. It aims to help the eye make its own medicine to stop harmful blood vessels from causing vision loss. This could reduce the need for regular injections. RGX-314 modifies the retina's cells to create a treatment that may only be needed once.

Recruiting

1 award

Phase 2 & 3

6 criteria